Edition:
United Kingdom

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

12.00USD
15 Dec 2017
Change (% chg)

$-0.10 (-0.83%)
Prev Close
$12.10
Open
$12.10
Day's High
$12.15
Day's Low
$12.00
Volume
14,664
Avg. Vol
15,964
52-wk High
$13.95
52-wk Low
$6.15

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -1.07 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 1 2 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.20 1.33 1.20 1.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Dec-17 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 3.33 16.67 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 3 -1.07 -0.98 -1.15 -1.27
Quarter Ending Mar-18 2 -1.11 -1.08 -1.14 --
Year Ending Dec-17 3 -4.82 -4.74 -4.87 -4.96
Year Ending Dec-18 5 -4.54 -3.63 -5.28 -4.53

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00
Quarter Ending Jun-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-17 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 3.33 3.33 2.78 3.33 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings